

![]() |
|||||||||||||
|
| All | Since 2021 | |
| Citation | 7304 | 4079 |
| h-index | 28 | 23 |
| i10-index | 181 | 77 |
Submit Article
Search
News & Updation
DEVELOPMENT AND EVALUATION OF FAST DISSOLVING TABLET OF DANTROLENE BY USING SOLID DISPERSION METHOD – A REVIEW
Shanti Saini*, Dr. Rajesh Asija
ABSTRACT Dantrolene sodium is a skeletal muscle relaxant widely prescribed for the treatment of chronic spasticity and malignant hyperthermia. Although it has immense therapeutic significance, its clinical performance is hindered by poor aqueous solubility, low dissolution rate, and limited oral bioavailability. As Dantrolene is classified under Biopharmaceutics Classification System (BCS) Class II, dissolution is the rate-limiting step in its absorption. To address these challenges, formulation scientists have explored solid dispersion (SD) methods to enhance solubility and dissolution. Fast dissolving tablets (FDTs), on the other hand, are an advanced oral dosage form that disintegrates rapidly in the oral cavity without the need for water, thus enhancing patient compliance and ensuring faster therapeutic onset. This review provides an in-depth analysis of the development and valuation of Dantrolene fast dissolving tablets prepared by solid dispersion methods. The review highlights the principles of solid dispersion, different carriers employed, methods of preparation, formulation aspects of FDTs, evaluation parameters, and potential future applications. The combined approach of SD and FDT not only improves bioavailability but also provides a patient-friendly, rapid-acting dosage form that may transform Dantrolene therapy. Keywords: Dantrolene sodium, Fast dissolving tablets, Solid dispersion, Solubility enhancement, Oral drug delivery. [Download Article] [Download Certifiate] |
